** Shares of weight-loss biotech firm Allurion Technologies ALUR.N fall 32.2% to $3.78
** ALUR says it is raising about $6.1 mln through a stock offering and private placement
** Company will sell 900,000 shares of common stock at $5.23/shr and issue warrants to purchase up to 1.8 mln shares
** Offering price is at a 6.3% discount to the stock's last close
** Funds will be used to advance company's clinical pipeline, including testing the effects of the Allurion Balloon and GLP-1 therapy - ALUR
** Roth Capital Partners is acting as the exclusive placement agent for the offering and private placement
** Company has 4.8 mln outstanding shares, with a market capitalization of $26.8 mln, according to data compiled by LSEG
** Stock fell 87.8% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。